Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region


Cite item

Full Text

Abstract

Aim. Assessment of prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region. Materials and methods. Cardiorespiratory monitoring was executed to 55 patients with acromegaly (18 men and 37 women): 27 patients with de novo disease, 28 patients on treatment of acromegaly (including 18 patietns with uncontrolled and 10 - with controlled acromegaly). All subgroups did not differ on sex, BMI and age. Also 24-hour monitoring of arterial blood pressure was carried out in 39 patients (12 men and 27 women, 14 patients with de novo acromegaly, 15 and 10 patients with uncontrolled and controlled acromegaly, respectively). Results and discussion. The high prevalence of sleep breathing disorders (SBD) was revealed in patients with acromegaly from Moscow Region. SBD was found in 92.6%, 83.5% and 70.0% patients with newly diagnosed, uncontrolled and controlled acromegaly, respectively. The majority of patients had severe/moderate SBD in all subgroups (78.8%, 72.2% and 60.0%, respectively). In patients with newly diagnosed and uncontrolled acromegaly index of apnea-hypopnea (31 and 38.5 respectively), number of apnoe episodes (76 and 72) and saturation level (93% and 93.5%) did not differ significantly while these parameters were better in patients with a controlled acromegaly (apnea-hypopnea index 20, apnea episodes 45.5 and saturation level 95%). The peak of desaturation was subphysiological in 91.7%, 86.7% and 77.8% of patients with newly diagnosed, uncontrolled and controlled acromegaly, respectively. Severity of SBD did not depend on GH and IGF-1 levels as well as acromegaly duration. Such all-population risk factors of SBD as BMI and age were valuable for patients with acromegaly, however gender did not matter. SBD were associated with lack of physiological decrease of systolic and diastolic night BP. Conclusion. Acromegaly per se is a strong risk factor of sleep breathing disorders. The high prevalence of sleep breathing disorders in patients with acromegaly even after achievement of control over a disease emphasized need of specialized treatment of these violations.

About the authors

Yu A Kovaleva

Moscow Regional Research and Clinical Institute («MONIKI»)

к.м.н., с.н.с. отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского Moscow, Russia

A V Dreval

Moscow Regional Research and Clinical Institute («MONIKI»)

д.м.н., проф., руководитель отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского Moscow, Russia

N V Kulakov

Moscow Regional Research and Clinical Institute («MONIKI»)

врач отд-ния функциональной диагностики, МОНИКИ им. М.Ф. Владимирского Moscow, Russia

S I Fedorova

Moscow Regional Research and Clinical Institute («MONIKI»)

к.м.н., руководитель отд-ния функциональной диагностики МОНИКИ им. М.Ф. Владимирского Moscow, Russia

I A Ilovayskaya

Moscow Regional Research and Clinical Institute («MONIKI»); A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

Email: irena.ilov@yandex.ru
к.м.н., с.н.с. отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского, доц. каф. поликлинической терапии МГМСУ им. А.И. Евдокимова Moscow, Russia

References

  1. Молитвословова Н.Н. Акромегалия. В кн.: Дедов И.И., Мельниченко Г.А., редакторы. Эндокринология. Национальное руководство. Москва: ГЭОТАР-Медиа; 2016. С. 766-777.
  2. Abreu A, Tovar A.P, Castellanos R, Valenzuela A, Giraldo C.M, Pinedo A.C, Guerrero D.P, Barrera C.A, Franco H.I, Ribeiro-Oliveira A.Jr, Vilar L, Jallad R.S, Duarte F.G, Gadelha M, Boguszewski C.L, Abucham J, Naves L.A, Musolino N.R, de Faria M.E, Rossato C, Bronstein M.D. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary. 2016 Aug;19(4):448-457. doi: 10.1007/s11102-016-0725-2
  3. Attal P, Chanson P. Endocrine Aspects of Obstructive Sleep Apnea. J Clin Endocrinol Metab. 2010;95(2):483-495. doi: 10.1210/jc.2009-1912
  4. Ceccato F, Bernkopf E, Scaroni C. Sleep apnea syndrome in endocrine clinics. J Endocrinol Invest. 2015 Aug;38(8):827-834. doi: 10.1007/s40618-015-0338-z
  5. Senaratna C.V, Perret J.L, Lodge C, Lowe A, Campbell B.E, Matheson M.C, Hamilton G.S, Dharmage S.C. Prevalence of Obstructive Sleep Apnea in the general population: A systematic review. Sleep Med Rev. 2017 Aug;34:70-81. doi: 10.1016/j.smrv.2016.07.002
  6. Цой У.А., Коростовцева Л.С., Свиряев Ю.В., Семенов А.П., Ваулина Д.А., Кравченко С.О., Конради А.О., Гринева Е.Н. Распространенность нарушений дыхания во сне у больных с впервые выявленной акромегалией. Альманах клинической медицины. 2014 (32):36-42. doi: 10.18786/2072-0505-2014-32-36-42
  7. Davì M.V, Dalle Carbonare L, Giustina A, et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol. 2008;159:533-540. doi: 10.1530/EJE-08-0442
  8. Pivonello R, Auriemma R.S, Grasso L.F, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7
  9. Powlson A.S, Gurnell M. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly. Neuroendocrinology. 2016;103(1):75-85. doi: 10.1159/ 000438903
  10. Somers V.K, White D.P, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association council for high blood pressure research professional education committee, Council on clinical cardiology, Stroke council, and Council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-1111. doi: 10.1161/Circulationaha.107.189375
  11. Kapur V.K, Auckley D.H, Chowdhuri S, Kuhlmann D.C, Mehra R, Ramar K, Harrod C.G. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An AmericanAcademy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504. doi: 10.5664/jcsm.6506
  12. Pedrosa R.P, Drager L.F, Gonzaga C.C, Sousa M.G, de Paula L.K, Amaro A.C, Amodeo C, Bortolotto L.A, Krieger E.M, Bradley T.D, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011 Nov;58(5):811-817. doi: 10.1161/Hypertensionaha.111.179788
  13. Muxfeldt E.S, Margallo V.S, Guimarães G.M, Salles G.F. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014 Aug;27(8):1069-1078. doi: 10.1093/ajh/hpu023
  14. Tolis G, Angelopoulos N.G, Katounda E, et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology. 2006;83:249-257. doi: 10.1159/000095535
  15. Цой У.А., Свиряев Ю.В., Коростовцева Л.С., Семенов А.П., Ваулина Д.А., Непран В.И., Кравченко С.О., Конради А.О., Гринева Е.Н. Клинические особенности синдрома нарушения дыхания во сне у больных акромегалией. Терапевтический архив. 2015;(4):47-52. doi: 10.17116/terarkh201587447-52
  16. Berg C, Wessendorf T.E, Mortsch F, Forsting M, Teschler H, Weischer T, Mann K, Saller B, Herrmann B.L. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur J Endocrinol. 2009;161:829-835. doi: 10.1530/EJE-09-0694

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies